Dr. Bannerji on Ongoing Research With REGN1979 in Non-Hodgkin Lymphoma
April 23rd 2020Rajat Bannerji, MD, PhD, hematologist/oncologist and chief of hematologic malignancies at the Rutgers Cancer Institute of New Jersey, discusses ongoing research with the bispecific antibody REGN1979 in non-Hodgkin lymphoma (NHL).
Read More
Dr. Bannerji on the Clinical Activity of the Bispecific Antibody REGN1979 in NHL
January 31st 2020Rajat Bannerji, MD, PhD, hematologist/oncologist and chief of hematologic malignancies at the Rutgers Cancer Institute of New Jersey, discusses the clinical activity of the bispecific antibody REGN1979 in patients with non-Hodgkin lymphoma (NHL).
Read More
Dr Marth on Frontline Lenvatinib Plus Pembrolizumab in Endometrial Cancer
Dr Mirza on the Findings From Part 2 of the RUBY Trial in Endometrial Cancer
Mahtani Emphasizes Empowering Women in Oncology Through Sponsorship, Support Networks, and Self Care
McCann on the Intersection of Mentorship, Multidisciplinary Care, and Career Aspirations as a Woman in Oncology
2 Commerce Drive
Cranbury, NJ 08512